US 7611722
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
granted A61KA61K31/195A61K31/216
Quick answer
US patent 7611722 (Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/195, A61K31/216, A61K31/4045, A61K31/433